Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 100 /hr

★★★★★

☆☆☆☆☆

Hire Emanuele A.

India

USD 100 /hr

Expert in HTA & Market Access, Health Policy, Evidence Generation, Digital Health & Stakeholder Engagement Leadership

Profile Summary

Independent Consultant | Market Access & HTA | Evidence Generation Strategy | Digital Health & AI in Healthcare I help small and medium-sized pharma, medtech, and digital health companies navigate the complex European market access and HTA landscape. With 10+ years of experience in EU health policy, HTA procedures, evidence synthesis, and digital health, I design and implement evidence-generation and market access strategies that accelerate adoption and reimbursement across European markets. Core expertise: - HTA Policy, Regulations & national HTA requirements - Market access strategy for SMEs and scale-ups in life sciences - Evidence synthesis & generation planning (clinical & economic) for innovative therapies and technologies - Digital health reimbursement pathways (DiGA in Germany, PECAN in France, NHS pilots, Nordic programs) - AI-driven health technologies: regulatory, evidence, and access implications - Stakeholder engagement with payers, clinicians, patients, and policymakers to shape access strategies - Policy & Consensus research leadership: Delphi studies and collaborative frameworks to inform HTA and access decisions across Europe What I offer - Strategic advice on early access planning & HTA readiness - Stakeholder engagement strategies that align company goals with payer and policy expectations - Tailored training workshops for SME teams on evidence and access requirements - Lead on evidence synthesis projects, including (systematic) literature reviews, HTA landscape assessment, policy analysis, and stakeholder mapping - Lead on consensus-building methods to generate actionable insights for cross-functional teams (clinical, medical affairs, patient engagement, and HTA & Access), including Delphi Panels, Nominal Group Technique, Focus Groups, and Advisory Boards - Support in dossier preparation, evidence gap analysis, and payer communication - Guidance for digital health startups on navigating reimbursement and evidence frameworks in Europe If you are a growing life sciences (pharma or medtech) or digital health company looking to strengthen your market access strategy, stakeholder engagement, and evidence base in Europe, I can provide practical, tailored support to help you reach patients faster and influence HTA and access environments effectively.

Subject Matter Expertise

• ☆ Health Policy
• ☆ Health Technology Assessment
• ☆ E-Health & Telemedicine
• ☆ Healthcare Administration & Management
• ☆ Medical Affairs
• ☆ Healthcare Reimbursement
• ☆ Literature Review
• ☆ Systematic Literature Review

Services

• Writing
• Research

Writing Medical Writing, Technical Writing, Creative Writing

Research Market Research, Feasibility Study, Gap Analysis, Gray Literature Search, Scientific and Technical Research, Systematic Literature Review, Secondary Data Collection

Work Experience

JCA Project Manager

UCB Pharmaceutical Company

August 2025 - Present

Researcher & Policy Advisor

Italian Society of AI in Medicine (SIIAM)

June 2024 - Present

Senior Consultant & Scientific Office Lead

Open Health

March 2018 - August 2025

Education

Pharmaceutical Policy Summer School

Utrecht University

June 2019 - July 2019

Health Economics, Policy, and Law

Erasmus University Rotterdam

September 2017 - September 2018

European Public Health

Maastricht University

September 2014 - August 2017

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Emanuele Arcà, Dorothea Heldt, Martina Smith (2025). Comparison of health technology assessments for digital therapeutics in Germany, the United Kingdom and France . DIGITAL HEALTH.